PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30873627-0	2019	A population pharmacokinetic model of vancomycin for dose individualization based on serum cystatin C as a marker of renal function.	Vancomycin	38-48	cystatin C	Homo sapiens	91-101	
30873627-1	2019	OBJECTIVES: This study aimed to establish a vancomycin population pharmacokinetics (PPK) model based on serum cystatin C and to optimize dosing for achieving targeted steady-state trough concentrations (Css ) of 10-15 and 15-20 mg/l.	Vancomycin	44-54	cystatin C	Homo sapiens	110-120	
30873627-3	2019	A vancomycin PPK model was built with glomerular filtration rate (GFR) as a renal covariate estimated by cystatin C.	Vancomycin	2-12	cystatin C	Homo sapiens	105-115	
30873627-11	2019	CONCLUSIONS: A vancomycin PPK model with cystatin C as the renal marker has good stability and predictability.	Vancomycin	15-25	cystatin C	Homo sapiens	41-51